Mylan CEO sold $5m worth of stock while EpiPen price drew scrutiny
Heather Bresch sold 100,200 of shares on same day as release of earnings;transaction was ‘part of a 10b5 plan’, which curtails insider trading suspicions
Continue Reading![](https://s0.storage.snapzu.com/favicons/t/h/e/g/www.theguardian.com.png)
Heather Bresch sold 100,200 of shares on same day as release of earnings;transaction was ‘part of a 10b5 plan’, which curtails insider trading suspicions
Continue Reading
Join the Discussion